Patent · US Active

Fumarate salts of a histamine H3 receptor antagonist

US8664245B2 · kind B2 · utility

1Cited by

5References

6Claims

0Family size

Assignee

Sanofi · FR

Inventors

Beverly C. Langevin · Stewartsville, US
Robert A. Farr · Loveland, US
Dinubhai H. Shah · Norristown, US
Daniel SHERER · Bound Brook, US

Key dates

Filing date	Dec 8, 2011
Grant date	Mar 4, 2014
Priority date	—
Expiry date	Dec 8, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/28
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure relates to fumarate salts of 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide, to pharmaceutical compositions thereof, processes for making the same, and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.